Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contrast-induced nephropathy: how it develops, how to prevent it.

Michael R Rudnick1, Aaron Kesselheim, Stanley Goldfarb

  • 1University of Pennsylvania School of Medicine, Philadelphia, USA. rudnickm@uphs.upenn.edu

Cleveland Clinic Journal of Medicine
|February 1, 2006
PubMed
Summary

Preventing contrast-induced nephropathy (CIN) is crucial as no cure exists. This review examines prophylactic strategies with proven or potential value for kidney protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient and population impacts of multigene panel and pembrolizumab coverage in metastatic melanoma.

Journal of the National Cancer Institute·2025
Same author

Contemporary contrast media dosing during percutaneous coronary intervention in patients with pre-existing renal impairment.

The Journal of invasive cardiology·2025
Same author

Reducing Contrast Volume to Protect the Kidneys: As Low as Reasonably Achievable.

Journal of the American College of Cardiology·2024
Same author

INTRODUCTION: <b>Promoting Drug and Vaccine Innovation and Managing High Prices:</b> Introducing a Special Symposium.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2024
Same author

Time to Embrace a Race-Agnostic eGFR Equation in Risk Assessment for CA-AKI Following Coronary Angiography.

JACC. Cardiovascular interventions·2023
Same author

Can Quality Improvement Reduce the Risk of Contrast-Associated Acute Kidney Injury?

Clinical journal of the American Society of Nephrology : CJASN·2023

Area of Science:

  • Nephrology
  • Radiology
  • Cardiology

Background:

  • Contrast-induced nephropathy (CIN) is a significant risk following radiocontrast administration.
  • Currently, no effective treatments can reverse CIN after onset, highlighting the need for preventive strategies.

Purpose of the Study:

  • To review and evaluate prophylactic measures for preventing contrast-induced nephropathy.
  • To focus on strategies with demonstrated or potential clinical value.

Main Methods:

  • Systematic review of existing literature.
  • Inclusion of only prospective, randomized, double-blinded trials evaluating prophylactic interventions.
  • Exclusion of studies with inadequate design or unproven efficacy.

Main Results:

Related Experiment Videos

  • Many previously suggested preventive measures have shown no benefit in rigorous clinical trials.
  • Certain prophylactic strategies demonstrate possible or proven value in reducing CIN incidence.
  • Evidence-based recommendations for CIN prophylaxis are derived from high-quality studies.

Conclusions:

  • Prophylaxis is the only viable approach to manage contrast-induced nephropathy.
  • Careful selection of prophylactic strategies based on robust evidence is essential for effective kidney protection.
  • Ongoing research is vital to further refine and validate CIN prevention methods.